151 related articles for article (PubMed ID: 6969974)
1. Circulating protein complexes in D-penicillamine therapy of rheumatoid arthritis. Correlation between IgG- and alpha 1-antitrypsin-IgA complexes and clinical response.
Norberg R; Wollheim FA; Gedda PO
Acta Med Scand; 1980; 208(5):393-6. PubMed ID: 6969974
[TBL] [Abstract][Full Text] [Related]
2. [Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis].
Schmidt KL; Ott VR
Z Rheumatol; 1976; 35(3-4):154-63. PubMed ID: 1266422
[TBL] [Abstract][Full Text] [Related]
3. Effects of D-penicillamine on circulating protein complexes in rheumatoid arthritis and primary biliary cirrhosis.
Wollheim FA
J Rheumatol Suppl; 1981; 7():74-9. PubMed ID: 7014877
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
Crawhall JC
Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
[TBL] [Abstract][Full Text] [Related]
5. [Effect of D-penicillamine on serum immunoglobulins in rheumatoid arthritis].
Gambari PF; Mioni E; Ostuni A; Volante D; Punzi L; Todesco S; Ongaro G
Boll Soc Ital Biol Sper; 1981 May; 57(10):1127-31. PubMed ID: 6794580
[TBL] [Abstract][Full Text] [Related]
6. Does IgA-alpha1 antitrypsin complex correlate with IgM, IgG and IgA rheumatoid factor in early rheumatoid arthritis?
Lacki JK; Hrycaj P; Klama K; Mackiewicz U; Mackiewicz SH; Muller W
Mater Med Pol; 1994; 26(3):97-100. PubMed ID: 7603085
[TBL] [Abstract][Full Text] [Related]
7. D-penicillamine treatment in rheumatoid arthritis monitored by plasma alfa-1-antitrypsin-IgA complexes and plasma and urinary sulphur containing aminoacids.
Wollheim FA; Jeppsson JO; Laurell CB
Scand J Rheumatol Suppl; 1979; (28):21-7. PubMed ID: 313074
[TBL] [Abstract][Full Text] [Related]
8. [Immunglobulin G-, M- and A-levels after 3 and 6 days intravenous treatment by D-penicillamin (author's transl)].
Cegla UH
Z Immunitatsforsch Exp Klin Immunol; 1975 Sep; 150(2):184-7. PubMed ID: 127474
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the complex of immunoglobulin A and alpha-1-antitrypsin, its constituent components and the acute-phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or D-penicillamine.
Dawes PT; Jackson R; Shadforth MF; Lewin IV; Stanworth DR
Br J Rheumatol; 1987 Oct; 26(5):351-3. PubMed ID: 2444302
[TBL] [Abstract][Full Text] [Related]
10. [Effect of clinical activity and D-penicillamine or gold treatment on the occurrence of serum immune complexes in patients with rheumatoid arthritis].
Brühl W; Swierczyńska Z; Cygler B; Woźniczko-Orłowska G
Reumatologia; 1979; 17(3):303-6. PubMed ID: 515575
[No Abstract] [Full Text] [Related]
11. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
[TBL] [Abstract][Full Text] [Related]
12. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
Sheĭtanov I
Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
[TBL] [Abstract][Full Text] [Related]
13. [Anti-IgG immunoglobulins of the IgG, IgA and IgM types in rheumatoid arthritis].
Stankaitene DI; Iushenaĭte IaP; Davidson LF
Vopr Revm; 1976; (1):7-12. PubMed ID: 1086548
[No Abstract] [Full Text] [Related]
14. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
[TBL] [Abstract][Full Text] [Related]
15. [A benign form of rheumatoid arthritis, associated with low IgG, IgM and IgA and C3-proactivator concentrations in the serum].
Stojan B; Hasler F
Z Rheumatol; 1980; 39(5-6):182-9. PubMed ID: 6903082
[TBL] [Abstract][Full Text] [Related]
16. [Level of secretory IgA in parotid saliva and serum concentrations of IgA, IgG, and IgM in patients with rheumatoid arthritis and in healthy subjects].
Luft S; Strauss MM; Glińska-Urban D
Reumatologia; 1976; 14(2):165-74. PubMed ID: 951546
[No Abstract] [Full Text] [Related]
17. Existence of disulfide-bonded IgM-IgA, IgM-IgG and IgM-IgG fragment complexes in one patient.
Zhang HS; Gallango ML; Tung E; Wang AC
Eur J Immunol; 1983 Dec; 13(12):1004-7. PubMed ID: 6662186
[TBL] [Abstract][Full Text] [Related]
18. [Two-phase course of IgM and rheumatoid factors during D-penicillamine therapy].
Stojan B; Hasler F
Z Rheumatol; 1977; 36(5-6):194-9. PubMed ID: 302538
[TBL] [Abstract][Full Text] [Related]
19. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
[TBL] [Abstract][Full Text] [Related]
20. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis.
Swedler W; Wallman J; Froelich CJ; Teodorescu M
J Rheumatol; 1997 Jun; 24(6):1037-44. PubMed ID: 9195506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
